These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34696947)

  • 21. Post-COVID Guillain-Barre Syndrome: Comparison of Two Reviews.
    Finsterer J
    Can J Neurol Sci; 2022 May; 49(3):474. PubMed ID: 34470678
    [No Abstract]   [Full Text] [Related]  

  • 22. Guillain Barre Syndrome associated with COVID-19 Infection: A Case Report.
    Shrestha S; Kc N; Hirachan N
    JNMA J Nepal Med Assoc; 2021 Aug; 59(240):808-811. PubMed ID: 34508476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Urodynamic AUR in Guillain-Barré syndrome post-infection by coronavirus Sars-CoV-2. A bibliographic review.].
    Méndez-Rubio S; Laso-Martín S; Jerez-Izquierdo T; Lorenzo-García C; López-Pérez E; Vives-Dilme R; Fernández-Hernández L; Méndez-Cea B; Moreno-Sierra J; Virseda-Chamorro M; Salinas-Casado J
    Arch Esp Urol; 2022 Jan; 75(1):7-18. PubMed ID: 35173070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late onset of Guillain-Barré syndrome following SARS-CoV-2 infection: part of 'long COVID-19 syndrome'?
    Raahimi MM; Kane A; Moore CE; Alareed AW
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autonomic dysfunction heralding acute motor axonal neuropathy in COVID-19.
    Ghosh R; Roy D; Sengupta S; Benito-León J
    J Neurovirol; 2020 Dec; 26(6):964-966. PubMed ID: 32918164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.
    Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A
    Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication.
    Chakraborty U; Hati A; Chandra A
    Diabetes Metab Syndr; 2021; 15(6):102326. PubMed ID: 34731822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Guillain-Barre syndrome associated with COVID-19].
    Bogdanova AA; Kravtsunova ES; Raevskaia AI; Karpov AS; Gadaborshev RN; Dzutsev AI; Vyshlova IA; Karpov SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9):132-136. PubMed ID: 36168699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2-associated Guillain-Barre syndrome requires extensive pre- and post-mortem examinations.
    Finsterer J; Scorza FA; Fiorini AC
    J Neurovirol; 2022 Dec; 28(4-6):622-623. PubMed ID: 35274197
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires cerebro-spinal-fluid studies.
    Finsterer J; Scorza FA; Scorza CA; Fiorini AC
    J Neuroimmunol; 2021 Aug; 357():577609. PubMed ID: 34023795
    [No Abstract]   [Full Text] [Related]  

  • 31. Response to: SARS-CoV-2 associated Guillain-Barré syndrome in 62 patients.
    Doneddu PE; De Sanctis P; Viganò L; Selmi C; Gentile F; Nobile-Orazio E
    Eur J Neurol; 2021 Jan; 28(1):e9. PubMed ID: 32978868
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiganglioside antibodies in Guillain-Barré syndrome associated with SARS-CoV-2 infection.
    Civardi C; Collini A; Geda DJ; Geda C
    J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1361-1362. PubMed ID: 32859744
    [No Abstract]   [Full Text] [Related]  

  • 33. Guillain-Barré/Miller Fisher overlap syndrome in a patient after coronavirus disease-2019 infection: a case report.
    Mohammadi SM; Abdi R; Karimi Z; Mortazavi F
    J Med Case Rep; 2022 Feb; 16(1):63. PubMed ID: 35135595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The first Hungarian patient with Guillain-Barre syndrome after COVID-19].
    Al-Muhanna N; Béres-Molnár AK; Jarecsny T; Folyovich A
    Ideggyogy Sz; 2021 Jan; 74(1-2):64-66. PubMed ID: 33497053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of acute motor and sensory axonal neuropathy following hepatitis a infection.
    Jo YS; Han SD; Choi JY; Kim IH; Kim YD; Na SJ
    J Korean Med Sci; 2013 Dec; 28(12):1839-41. PubMed ID: 24339719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [COVID-19-associated damage of the peripheral nervous system].
    Burd SG; Lebedeva AV; Avakyan GG; Rubleva YV; Pantina NV; Yurchenko AV; Kovaleva II
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9):15-21. PubMed ID: 36168683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 and Guillain-Barré Syndrome: Lessons from Viral Infections.
    Meidaninikjeh S; Sabouni N; Taheri M; Borjkhani M; Bengar S; Majidi Zolbanin N; Khalili A; Jafari R
    Viral Immunol; 2022 Jul; 35(6):404-417. PubMed ID: 35766944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post SARS-CoV-2 Guillain-Barré syndrome in a child: case report and review of the literature.
    Al Jaberi M; Shihadat R; Masri A
    Childs Nerv Syst; 2022 Oct; 38(10):2011-2016. PubMed ID: 35461356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2-associated Guillain-Barre syndrome in 62 patients.
    Finsterer J; Scorza FA; Fiorini AC
    Eur J Neurol; 2021 Jan; 28(1):e10-e12. PubMed ID: 32978857
    [No Abstract]   [Full Text] [Related]  

  • 40. Exacerbation of diabetic neuropathy can mimic SARS-CoV-2 associated pure dysautonomic Guillain-Barre syndrome.
    Finsterer J
    J Neurovirol; 2022 Feb; 28(1):187-188. PubMed ID: 35212943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.